Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytokinetics (NQ: CYTK )

67.55 +0.55 (+0.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,607,375
Open 66.88
Bid (Size) 65.25 (1)
Ask (Size) 74.50 (2)
Prev. Close 67.00
Today's Range 64.81 - 67.80
52wk Range 25.98 - 110.25
Shares Outstanding 95,640,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Incredible Growth Stocks to Buy Right Now
These two biotech stocks could be big winners in the years ahead. 
Via The Motley Fool

Performance

YTD
-19.70%
-19.70%
1 Month
-0.06%
-0.06%
3 Month
-18.36%
-18.36%
6 Month
+105.88%
+105.88%
1 Year
+78.09%
+78.09%

More News

Read More
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Masters In Trading - Saturday, March 16
Via Talk Markets
Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
Via Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Via InvestorPlace
Unpacking the Latest Options Trading Trends in Cytokinetics
Via Benzinga
Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Super Micro, Deckers To Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Overbought, Overextended - What's The Buzz In S&P 500 Now?
Via Talk Markets
Topics Stocks
Exposures US Equities
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
Via Benzinga
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
Via InvestorPlace
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
Via Investor's Business Daily
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
Via Benzinga
Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
Via InvestorPlace
Biotech Playbook: Small Caps Show Momentum Peaking During
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
Via Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Bullish Continuation In '24? 3 Market Areas To Watch
Via Talk Markets
What's Been Happening With Cytokinetics Stock?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.